Subjects -> HEALTH AND SAFETY (Total: 1478 journals)
    - CIVIL DEFENSE (22 journals)
    - DRUG ABUSE AND ALCOHOLISM (87 journals)
    - HEALTH AND SAFETY (700 journals)
    - HEALTH FACILITIES AND ADMINISTRATION (358 journals)
    - OCCUPATIONAL HEALTH AND SAFETY (112 journals)
    - PHYSICAL FITNESS AND HYGIENE (117 journals)
    - WOMEN'S HEALTH (82 journals)

HEALTH AND SAFETY (700 journals)            First | 1 2 3 4     

Showing 601 - 203 of 203 Journals sorted alphabetically
Saúde Coletiva     Open Access  
Saúde e Meio Ambiente : Revista Interdisciplinar     Open Access  
Saúde em Redes     Open Access  
Saúde.com     Open Access  
Scandinavian Journal of Work, Environment & Health     Partially Free   (Followers: 13)
School Mental Health     Hybrid Journal   (Followers: 8)
Scientia Medica     Open Access  
Scire Salutis     Open Access  
Serviço Social e Saúde     Open Access  
Sextant : Revue de recherche interdisciplinaire sur le genre et la sexualité     Open Access   (Followers: 1)
Sexual Health     Hybrid Journal   (Followers: 3)
Sexual Medicine Reviews     Full-text available via subscription   (Followers: 1)
Sierra Leone Journal of Biomedical Research     Open Access  
Sleep and Vigilance : An International Journal of Basic, Translational and Clinical Research     Hybrid Journal  
Sleep Health     Full-text available via subscription   (Followers: 3)
Sleep Science and Practice     Open Access  
SMAD, Revista Electronica en Salud Mental, Alcohol y Drogas     Open Access   (Followers: 2)
Smart Health     Hybrid Journal  
Social Determinants of Health     Open Access   (Followers: 1)
Social Theory & Health     Hybrid Journal   (Followers: 3)
Social Work in Health Care     Hybrid Journal   (Followers: 24)
Social Work in Mental Health     Hybrid Journal   (Followers: 15)
Social Work in Public Health     Hybrid Journal   (Followers: 13)
Society, Health & Vulnerability     Open Access   (Followers: 4)
Sosiaalilääketieteellinen Aikakauslehti     Open Access  
South African Family Practice     Open Access   (Followers: 3)
South African Journal of Bioethics and Law     Open Access   (Followers: 1)
South African Journal of Child Health     Open Access   (Followers: 1)
South African Journal of Communication Disorders     Open Access   (Followers: 1)
South East Asia Journal of Public Health     Open Access   (Followers: 3)
South Eastern European Journal of Public Health     Open Access   (Followers: 1)
Southern African Journal of Critical Care     Open Access   (Followers: 4)
Southern African Journal of Public Health     Open Access  
Southwest Respiratory and Critical Care Chronicles     Open Access   (Followers: 1)
Space Safety Magazine     Free   (Followers: 50)
Sri Lanka Journal of Child Health     Open Access  
SSM - Population Health     Open Access   (Followers: 4)
SSM - Qualitative Research in Health     Open Access  
Stigma and Health     Full-text available via subscription   (Followers: 1)
Sundhedsprofessionelle studier     Open Access  
Sustainable Earth     Open Access   (Followers: 1)
Sustinere : Revista de Saúde e Educação     Open Access  
System Safety : Human - Technical Facility - Environment     Open Access   (Followers: 2)
Systematic Reviews     Open Access   (Followers: 11)
Tanzania Journal of Health Research     Open Access   (Followers: 2)
Technology and Innovation     Full-text available via subscription   (Followers: 3)
Tempus Actas de Saúde Coletiva     Open Access  
Textos & Contextos (Porto Alegre)     Open Access  
The Journal of Aquatic Physical Therapy     Full-text available via subscription   (Followers: 1)
The Journal of Rural Health     Hybrid Journal   (Followers: 7)
The Lancet Child & Adolescent Health     Hybrid Journal   (Followers: 3)
The Lancet Global Health     Open Access   (Followers: 71)
The Lancet Planetary Health     Open Access   (Followers: 1)
The Lancet Regional Health : Americas     Open Access  
The Lancet Regional Health : Europe     Open Access   (Followers: 1)
The Lancet Regional Health : Western Pacific     Open Access   (Followers: 2)
The Meducator     Open Access   (Followers: 1)
Theoretical Issues in Ergonomics Science     Hybrid Journal   (Followers: 6)
Therapeutic Communities : The International Journal of Therapeutic Communities     Hybrid Journal   (Followers: 23)
Tidsskrift for Forskning i Sygdom og Samfund     Open Access  
Tidsskrift for psykisk helsearbeid     Full-text available via subscription  
Tobacco Control     Hybrid Journal   (Followers: 15)
Tobacco Control and Public Health in Eastern Europe     Open Access   (Followers: 2)
Transgender Health     Open Access   (Followers: 3)
Transportation Safety and Environment     Open Access   (Followers: 1)
Tropical Journal of Health Sciences     Full-text available via subscription  
Tropical Medicine and Health     Open Access  
TÜBAV Bilim Dergisi     Open Access  
Universal Journal of Public Health     Open Access  
Universidad y Salud     Open Access  
Unnes Journal of Public Health     Open Access  
Value in Health Regional Issues     Hybrid Journal  
Vascular Health and Risk Management     Open Access   (Followers: 2)
Vigilância Sanitária em Debate     Open Access  
Violence and Gender     Full-text available via subscription   (Followers: 21)
Water Quality, Exposure and Health     Hybrid Journal   (Followers: 2)
Western Pacific Surveillance and Response     Open Access  
Women & Health     Hybrid Journal   (Followers: 8)
World Health & Population     Full-text available via subscription   (Followers: 3)
World Medical & Health Policy     Hybrid Journal   (Followers: 2)
Zeitschrift für Arbeitswissenschaft     Hybrid Journal  
Електромагнітна сумісність та безпека на залізничному транспорті     Open Access  
مجله بهداشت و توسعه     Open Access  

  First | 1 2 3 4     

Similar Journals
Journal Cover
The Lancet Global Health
Journal Prestige (SJR): 8.756
Citation Impact (citeScore): 4
Number of Followers: 71  

  This is an Open Access Journal Open Access journal
ISSN (Print) 2214-109X
Published by Elsevier Homepage  [2906 journals]
  • [Editorial] Infertility—why the silence'

    • Authors: The Lancet Global Health
      Abstract: The most common story of the state of reproductive health in many low- and middle-income countries is one of high rates of fertility, limited access to and low use of contraception, and high unmet need for family planning information and services. Indeed, the evidence on these issues is clear, as shown in many research articles and comments published in this journal. But there's one aspect of reproductive health that's conspicuously side-lined from global health research and policy today—infertility.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00215-7
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Comment] Intimate partner violence among women with infertility

    • Authors: Christine Bourey; Sarah Murray
      Abstract: Intimate partner violence (IPV) represents a critical public health problem that impacts mental, physical, and reproductive health throughout the life-course. Infertility is not only an issue of reproductive health, but also a social issue that can influence marital, family, and other interpersonal relationships, particularly in settings where childbearing is highly valued and central to ideas of womanhood. Women experiencing infertility might be socially sanctioned for childlessness or small family sizes in cultures where progeny is among what matters most.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00205-4
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Comment] Precision in prescription: multiple micronutrient supplements in
           pregnancy

    • Authors: Anura V Kurpad; Harshpal Singh Sachdev
      Abstract: The programmatic possibility of introducing multiple micronutrient supplements (MMS), which include iron and folic acid, for routine antenatal care in low-income and middle-income countries (LMIC) has been enthusiastically welcomed by many, but it is equally opposed by others. This is reflected in the language of the WHO recommendation,1 which states that more rigorous research is required, specifically, using early ultrasound to date pregnancies accurately and to rigorously evaluate outcomes and the follow-up of infants into childhood.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00207-8
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Comment] Creating healthy and sustainable cities: what gets measured,
           gets done

    • Authors: Billie Giles-Corti; Anne Vernez Moudon, Melanie Lowe, Deepti Adlakha, Ester Cerin, Geoff Boeing, Carl Higgs, Jonathan Arundel, Shiqin Liu, Erica Hinckson, Deborah Salvo, Marc A Adams, Hannah Badland, Alex A Florindo, Klaus Gebel, Ruth F Hunter, Josef Mitáš, Adewale L Oyeyemi, Anna Puig-Ribera, Ana Queralt, Maria Paula Santos, Jasper Schipperijn, Mark Stevenson, Delfien Van Dyck, Guillem Vich, James F Sallis
      Abstract: Since the first Lancet Series on urban design, transport, and health (Series 1) was published in 2016, the urgency to make the transition to healthy and sustainable cities worldwide has intensified. That year, the UN's Sustainable Development Goals1 for promoting prosperity while protecting the planet and ensuring equity came into force. WHO also released its Shanghai Declaration on promoting health in the 2030 Agenda for Sustainable Development. At WHO Global Conference on non-communicable diseases (NCDs) in 2017, heads of states reiterated their commitment to reduce premature mortality from NCDs by a third by 2030.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00070-5
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Comment] Urban design is key to healthy environments for all

    • Authors: Thiago Herick de Sa; Abraham Mwaura, Cristina Vert, Pierpaolo Mudu, Nathalie Roebbel, Nhan Tran, Maria Neira
      Abstract: Rapidly increasing urbanisation along with ageing populations, climate change, environmental degradation, COVID-19, and other pandemics present substantial challenges for people living in cities and other communities. The capacity to identify and respond to urban challenges related to health, equity, and sustainability varies greatly across national and subnational governments around the globe, because of the available human and financial resources, structures of governance and participation, and existing policy frameworks, which are all important determinants of healthy and sustainable urban environments.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00202-9
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Comment] Measuring what matters: supporting cities in tackling climate
           and health challenges

    • Authors: Honorine van den Broek d’Obrenan; Rachel Huxley
      Abstract: The effects of climate change are inextricably linked with wider health and social challenges. We at C40 Cities—the network of mayors worldwide collaborating to confront the climate crisis—see daily how inequality and illness share similar root causes to the climate crisis. We work with public health teams trying to tackle the obesity and diabetes emergency; air quality officers aiming to reduce urban pollution; and city planners wanting to address traffic, fair access to services, or rising carbon emissions.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00198-X
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Comment] The future is urban: integrated planning policies can enable
           healthy and sustainable cities

    • Authors: Deepti Adlakha; Felix John
      Abstract: The world's urban population has increased drastically during the last century. At the turn of the 20th century, approximately 10% of people lived in cities. By 1950, the world's urban population had grown to 29%.1 Today, more than half of the world's population resides in cities. By 2050, it is expected that at least two-thirds of the world's population, or nearly 7 of 10 people, will live in cities.2 The largest share of this tremendous urban growth will occur in low-income and middle-income countries (LMICs), in cities already carrying a disproportionate share of the global disease burden.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00211-X
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Correspondence] The optimal screening strategy for chronic hepatitis B
           virus infection in China

    • Authors: Jue Liu; Min Liu
      Abstract: Shu Su and colleagues (February, 2022),1 in their Article on the cost-effectiveness of universal screening for chronic hepatitis B virus (HBV) infection in China, found that the five-test universal screening strategy in people aged 18–70 years, implemented within the next 10 years, is the optimal HBV screening strategy for China.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00169-3
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Correspondence] The optimal screening strategy for chronic hepatitis B
           virus infection in China – Authors' reply

    • Authors: Shu Su; William CW Wong, Jason J Ong, Wai-Kay Seto, Lei Zhang
      Abstract: We thank Min Liu and Jue Liu for taking the time to read our study and respond to our published manuscript.1 They suggest that hepatitis B virus (HBV) screening for key groups and groups at high risk might be a better strategy for China to achieve the 2030 HBV elimination target than by universal screening. Although targeted screening has its advantages in reducing the initial monetary investment and can be implemented in resource-scarce settings, identifying the key groups and groups at high risk themselves could be a major barrier for its implementation.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00165-6
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Correspondence] Misunderstanding poor adherence to COVID-19 vaccination
           in Africa

    • Authors: Bernard Seytre
      Abstract: Although I can only applaud the call to action in favour of COVID-19 vaccination in Africa by Polydor Ngoy Mutombo and colleagues (March, 2022),1 their analysis of so-called COVID-19 vaccine hesitancy is questionable.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00181-4
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Correspondence] Misunderstanding poor adherence to COVID-19 vaccination
           in Africa – Authors' reply

    • Authors: Polydor Ngoy Mutombo; Mosoka P Fallah, Davison Munodawafa, Ahmed Kabel, David Houeto, Tinashe Goronga, Oliver Mweemba, Gladys Balance, Hans Onya, Roger S Kamba, Miriam Chipimo, Jean-Marie Ntumba Kayembe, Bartholomew Akanmori
      Abstract: We welcome Bernard Seytre's engagement with our Comment.1 However, his response leaves us more perplexed than enlightened. It is not clear whether Seytre is questioning the sources or disputing the facts. In any event, a careful reader of the US study we cited,2 for example, will find therein explicit treatment of racism, medical abuse, and public trust (page 2 of the study). This finding has direct bearing on vaccine hesitancy and the history of colonial medicine and medical abuse in Africa, as shown by several studies (see Lowes and colleagues for a sample).
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00179-6
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Correspondence] Barriers to statin use in the Philippines

    • Authors: Katrina T Feliciano; Robyn Gayle K Dychiao, Michelle Ann B Eala, Joseph Alexander Paguio, Renzo R Guinto
      Abstract: Maja Marcus and colleagues (March, 2022)1 show that, between 2013 and 2019, 41 low-income and middle-income countries (LMICs) failed to meet the WHO targets for statin use in preventing cardiovascular disease. We write from the perspective of the Philippines—a southeast Asian LMIC, where cardiovascular disease has been the leading cause of death for the past 33 years.2 Challenges in health financing, health infrastructure, and health-service delivery are among the substantial barriers to increasing statin use in the country.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00201-7
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Correspondence] Correction to Lancet Glob Health 2022; 10: e530–42

    • Abstract: Asher L, Birhane R, Weiss HA, et al. Community-based rehabilitation intervention for people with schizophrenia in Ethiopia (RISE): results of a 12-month cluster-randomised controlled trial. Lancet Glob Health 2022; 10: e530–42—In this Article the acknowledgments have been corrected to add “MDS was not employed by the Wellcome Trust at the time of the study.” This correction has been made as of May 10, 2022.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00216-9
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Articles] Prevalence of intimate partner violence against infertile women
           in low-income and middle-income countries: a systematic review and
           meta-analysis

    • Authors: Yuanyuan Wang; Yu Fu, Parastou Ghazi, Qin Gao, Tian Tian, Fei Kong, Siyan Zhan, Chaojie Liu, David E Bloom, Jie Qiao
      Abstract: A high prevalence of IPV against infertile women is evident despite heterogeneity across studies. IPV screening, counselling, and structural interventions should be tailored to address this urgent issue at multiple levels of society.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00098-5
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Articles] Iron, folic acid, and multiple micronutrient supplementation
           strategies during pregnancy and adverse birth outcomes in Botswana

    • Authors: Ellen C Caniglia; Rebecca Zash, Sonja A Swanson, Emily Smith, Christopher Sudfeld, Julia L Finkelstein, Modiegi Diseko, Gloria Mayondi, Mompati Mmalane, Joseph Makhema, Wafaie Fawzi, Shahin Lockman, Roger L Shapiro
      Abstract: Nationwide data from Botswana support improved birth outcomes with MMS compared with IFAS.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00126-7
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Articles] Human versus equine intramuscular antitoxin, with or without
           human intrathecal antitoxin, for the treatment of adults with tetanus: a
           2 × 2 factorial randomised controlled trial

    • Authors: Nguyen Van Hao; Huynh Thi Loan, Lam Minh Yen, Evelyne Kestelyn, Duc Du Hong, Duong Bich Thuy, Nguyen Thanh Nguyen, Ha Thi Hai Duong, Tran Thi Diem Thuy, Phung Tran Huy Nhat, Phan Nguyen Quoc Khanh, Nguyen Thi Phuong Dung, Nguyen Hoan Phu, Nguyen Thanh Phong, Pham Thi Lieu, Pham Thi Tuyen, Bui Thi Bich Hanh, Ho Dang Trung Nghia, Pham Kieu Nguyet Oanh, Phan Vinh Tho, Tran Tan Thanh, Hugo C Turner, H Rogier van Doorn, Le Van Tan, Duncan Wyncoll, Nicholas PJ Day, Ronald B Geskus, Guy E Thwaites, Nguyen Van Vinh Chau, C Louise Thwaites
      Abstract: We found no advantage of intramuscular human antitoxin over intramuscular equine antitoxin in tetanus treatment. Intrathecal antitoxin administration was safe, but did not provide overall benefit in addition to intramuscular antitoxin administration.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00117-6
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Articles] The epidemiology of severe malaria at Manhiça District
           Hospital, Mozambique: a retrospective analysis of 20 years of malaria
           admissions surveillance data

    • Authors: Caterina Guinovart; Betuel Sigaúque, Quique Bassat, Mari Paz Loscertales, Tacilta Nhampossa, Sozinho Acácio, Sónia Machevo, Sónia Maculuve, Gisela Bambo, Hélio Mucavele, Montse Soriano-Gabarró, Abuchahama Saifodine, Ariel Nhacolo, Delino Nhalungo, Charfudin Sacoor, Francisco Saúte, John J Aponte, Clara Menéndez, Eusébio Macete, Pedro L Alonso
      Abstract: Despite the unprecedented scale up of malaria control tools, malaria still represented around 30–40% of paediatric hospital admissions in 2006–17. The age shift towards older children was not accompanied by an increase in severe malaria or deaths; however, control programmes should consider adapting their high-risk target groups to include older children. Malaria remains a leading cause of disease and health-care system use and the massive unfinished malaria control agenda warrants intensified efforts.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00125-5
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Series] City planning policies to support health and sustainability: an
           international comparison of policy indicators for 25 cities

    • Authors: Melanie Lowe; Deepti Adlakha, James F Sallis, Deborah Salvo, Ester Cerin, Anne Vernez Moudon, Carl Higgs, Erica Hinckson, Jonathan Arundel, Geoff Boeing, Shiqin Liu, Perla Mansour, Klaus Gebel, Anna Puig-Ribera, Pinki Bhasin Mishra, Tamara Bozovic, Jacob Carson, Jan Dygrýn, Alex A Florindo, Thanh Phuong Ho, Hannah Hook, Ruth F Hunter, Poh-Chin Lai, Javier Molina-García, Kornsupha Nitvimol, Adewale L Oyeyemi, Carolina D G Ramos, Eugen Resendiz, Jens Troelsen, Frank Witlox, Billie Giles-Corti
      Abstract: City planning policies influence urban lifestyles, health, and sustainability. We assessed policy frameworks for city planning for 25 cities across 19 lower-middle-income countries, upper-middle-income countries, and high-income countries to identify whether these policies supported the creation of healthy and sustainable cities. We systematically collected policy data for evidence-informed indicators related to integrated city planning, air pollution, destination accessibility, distribution of employment, demand management, design, density, distance to public transport, and transport infrastructure investment.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00069-9
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Series] Determining thresholds for spatial urban design and transport
           features that support walking to create healthy and sustainable cities:
           findings from the IPEN Adult study

    • Authors: Ester Cerin; James F Sallis, Deborah Salvo, Erica Hinckson, Terry L Conway, Neville Owen, Delfien van Dyck, Melanie Lowe, Carl Higgs, Anne Vernez Moudon, Marc A Adams, Kelli L Cain, Lars Breum Christiansen, Rachel Davey, Jan Dygrýn, Lawrence D Frank, Rodrigo Reis, Olga L Sarmiento, Deepti Adlakha, Geoff Boeing, Shiqin Liu, Billie Giles-Corti
      Abstract: An essential characteristic of a healthy and sustainable city is a physically active population. Effective policies for healthy and sustainable cities require evidence-informed quantitative targets. We aimed to identify the minimum thresholds for urban design and transport features associated with two physical activity criteria: at least 80% probability of engaging in any walking for transport and WHO's target of at least 15% relative reduction in insufficient physical activity through walking. The International Physical Activity and the Environment Network Adult (known as IPEN) study (N=11 615; 14 cities across ten countries) provided data on local urban design and transport features linked to walking.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00068-7
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Series] Using open data and open-source software to develop spatial
           indicators of urban design and transport features for achieving healthy
           and sustainable cities

    • Authors: Geoff Boeing; Carl Higgs, Shiqin Liu, Billie Giles-Corti, James F Sallis, Ester Cerin, Melanie Lowe, Deepti Adlakha, Erica Hinckson, Anne Vernez Moudon, Deborah Salvo, Marc A Adams, Ligia V Barrozo, Tamara Bozovic, Xavier Delclòs-Alió, Jan Dygrýn, Sara Ferguson, Klaus Gebel, Thanh Phuong Ho, Poh-Chin Lai, Joan C Martori, Kornsupha Nitvimol, Ana Queralt, Jennifer D Roberts, Garba H Sambo, Jasper Schipperijn, David Vale, Nico Van de Weghe, Guillem Vich, Jonathan Arundel
      Abstract: Benchmarking and monitoring of urban design and transport features is crucial to achieving local and international health and sustainability goals. However, most urban indicator frameworks use coarse spatial scales that either only allow between-city comparisons, or require expensive, technical, local spatial analyses for within-city comparisons. This study developed a reusable, open-source urban indicator computational framework using open data to enable consistent local and global comparative analyses.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00072-9
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Series] What next' Expanding our view of city planning and global
           health, and implementing and monitoring evidence-informed policy

    • Authors: Billie Giles-Corti; Anne Vernez Moudon, Melanie Lowe, Ester Cerin, Geoff Boeing, Howard Frumkin, Deborah Salvo, Sarah Foster, Alexandra Kleeman, Sarah Bekessy, Thiago Hérick de Sá, Mark Nieuwenhuijsen, Carl Higgs, Erica Hinckson, Deepti Adlakha, Jonathan Arundel, Shiqin Liu, Adewale L Oyeyemi, Kornsupha Nitvimol, James F Sallis
      Abstract: This Series on urban design, transport, and health aimed to facilitate development of a global system of health-related policy and spatial indicators to assess achievements and deficiencies in urban and transport policies and features. This final paper in the Series summarises key findings, considers what to do next, and outlines urgent key actions. Our study of 25 cities in 19 countries found that, despite many well intentioned policies, few cities had measurable standards and policy targets to achieve healthy and sustainable cities.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-06
      DOI: 10.1016/S2214-109X(22)00066-3
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Comment] Variation of invasive neonatal GBS disease across the regions

    • Authors: Musa Mohammed Ali; Daniel Asrat
      Abstract: Group B streptococcus (GBS) emerged in the 1960s as the leading cause of neonatal disease in the USA,1 and yet the reason for its emergence is unknown. Possible reasons are past underdiagnosis or a change in the population structure of GBS.2 Intrapartum antibiotic prophylaxis (IAP) was recommended as the prevention strategy for early-onset invasive GBS (EOGBS),3 and was adopted by various high-income countries. As a result, a substantial decline in the incidence of neonatal disease was observed.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-04-28T22:30:02Z
      DOI: 10.1016/S2214-109X(22)00182-6
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Articles] Group B streptococcus infection during pregnancy and infancy:
           estimates of regional and global burden

    • Authors: Bronner P Gonçalves; Simon R Procter, Proma Paul, Jaya Chandna, Alexandra Lewin, Farah Seedat, Artemis Koukounari, Ziyaad Dangor, Shannon Leahy, Sridhar Santhanam, Hima B John, Justina Bramugy, Azucena Bardají, Amina Abubakar, Carophine Nasambu, Romina Libster, Clara Sánchez Yanotti, Erzsébet Horváth-Puhó, Henrik T Sørensen, Diederik van de Beek, Merijn W Bijlsma, William M Gardner, Nicholas Kassebaum, Caroline Trotter, Quique Bassat, Shabir A Madhi, Philipp Lambach, Mark Jit, Joy E Lawn, GBS Danish Middle Income Countries collaborative group for long term outcomes, GBS Scientific Advisory Group, epidemiological sub-group, CHAMPS team
      Abstract: Our analysis provides a comprehensive assessment of the pregnancy-related GBS burden. The Bayesian approach enabled coherent propagation of uncertainty, which is considerable, notably regarding GBS-associated preterm births. Our findings on both the acute and long-term consequences of iGBS have public health implications for understanding the value of investment in maternal GBS immunisation and other preventive strategies.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-04-28T22:30:02Z
      DOI: 10.1016/S2214-109X(22)00093-6
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Comment] COVID-19 vaccine booster strategy: striving for best practice

    • Authors: Mine Durusu Tanriover; Murat Akova
      Abstract: As we enter the third year of the COVID-19 pandemic, policy makers need pragmatic data about the performance of the different vaccination regimens for informed decisions and prioritisation, because placebo-controlled studies are no longer feasible for ethical reasons. Furthermore, there is a need for evidence of the protective effectiveness of the vaccines against symptomatic or severe COVID-19 in real-world settings, in which unselected individuals from every age and different risk groups are vaccinated.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-04-23T22:30:01Z
      DOI: 10.1016/S2214-109X(22)00204-2
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Articles] Effectiveness of homologous and heterologous booster doses for
           

    • Authors: Alejandro Jara; Eduardo A Undurraga, José R Zubizarreta, Cecilia González, Alejandra Pizarro, Johanna Acevedo, Katherinne Leo, Fabio Paredes, Tomás Bralic, Verónica Vergara, Marcelo Mosso, Francisco Leon, Ignacio Parot, Paulina Leighton, Pamela Suárez, Juan Carlos Rios, Heriberto García-Escorza, Rafael Araos
      Abstract: Our results suggest that a homologous or heterologous booster dose for individuals with a complete primary vaccination schedule with CoronaVac provides a high level of protection against COVID-19, including severe disease and death. Heterologous boosters showed higher vaccine effectiveness than a homologous booster for all outcomes, providing additional support for a mix-and-match approach.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-04-23T22:30:01Z
      DOI: 10.1016/S2214-109X(22)00112-7
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Articles] The seasonality of cholera in sub-Saharan Africa: a statistical
           modelling study

    • Authors: Javier Perez-Saez; Justin Lessler, Elizabeth C Lee, Francisco J Luquero, Espoir Bwenge Malembaka, Flavio Finger, José Paulo Langa, Sebastian Yennan, Benjamin Zaitchik, Andrew S Azman
      Abstract: Widespread cholera seasonality in SSA offers opportunities for intervention planning. Further studies are needed to study the association between cholera and climate.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-04-21T22:30:03Z
      DOI: 10.1016/S2214-109X(22)00007-9
      Issue No: Vol. 10, No. 6 (2022)
       
  • [Articles] Estimating the cost of achieving basic water, sanitation,
           hygiene, and waste management services in public health-care facilities in
           the 46 UN designated least-developed countries: a modelling study

    • Authors: Michael Chaitkin; Samantha McCormick, Jorge Alvarez-Sala Torreano, Irene Amongin, Silvia Gaya, Odd N Hanssen, Richard Johnston, Tom Slaymaker, Claire Chase, Guy Hutton, Maggie Montgomery
      Abstract: Investment will need to increase to reach full coverage of basic WASH and waste services in public health facilities. Financial needs are modest compared with current overall health and WASH spending, and better service coverage will yield substantial health benefits. To sustain services and prevent degradation and early replacement, countries will need to routinely budget for operations and maintenance of WASH and waste management assets.
      Citation: The Lancet Global Health 10, 6 (2022)
      PubDate: 2022-04-06T22:30:01Z
      DOI: 10.1016/S2214-109X(22)00099-7
      Issue No: Vol. 10, No. 6 (2022)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.238.136.36
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-